🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It was great to host Chi Onwurah 💙 at @AMLoBiosciences in our offices and lab The Biosphere and show her the work we are doing with our AMBLor test. Using AMBLor can help alleviate patient anxiety by identifying those melanomas at low risk of spread. Northern Accelerator Newcastle Helix

Fabulous to see recognition for AMLo Biosciences CSO Penny Lovat at #BAD2023. She presented the latest validation data for #AMBLor showing it’s utility in identifying genuinely low-risk, early- stage melanomas.

Disappointed that The Sightseeing Pass is advertising a NY city pass for attractions with unlimited hop on hop off bus for the duration of the pass, only to find that the bus pass is for one day only! FAQs clearly stated it’s valid for whole trip. Company dismissive- best avoided!

Interesting article from Cancer Research UK. Melanoma continues to increase. In older people exposure to UV in their youth is leading the skin cancers in later life. @AMLoBiosciences is developing tests to help the NHS manage this time bomb by improving patient management and anxiety.

Was great to attend this event at NHS England and talk to Chris Bryant about our innovate prognostic test for early stage melanoma. AMBLor was discovered using funding from Melanoma Focus UK and we are striving to make AMBLor available for NHS patients. . #melanoma

Fabulous to see @AMLoBiosciences own Jane Meaney talking to Chi Onwurah 💙 about our prognostic test for early-stage melanoma.

Are current follow-up recommendations for melanoma patients adequate? Unfortunately this study found that evidence supporting current guidance is sparse. The use of a biomarker test #AMBLor could help direct appropriate follow up for melanoma patients. AMLo Biosciences

No one likes late surprises in early stage melanoma: “Surprisingly 25% of distant metastases occurred 5 years or later” -stage I/II data from Yevgeniy Semenov MassGeneral Medicine #SMR23 Society For Melanoma Research More to come soon from David Savage Ben Switzer Rujul Parikh, MD #spoilers

As a company @AMLoBiosciences are working hard to bring innovate products to market to facilitate personalised care for people with melanoma. An important consequence of this is the more effective use of healthcare resources and the reduction of waste. #RealisticMed #AMBLor

The programme features a visit to Newcastle University that, with funding from us, has developed a pioneering test which reliably predicts which people's early-stage melanomas are at low risk of recurring.  business.itn.co.uk/programmes/sha… AMLo Biosciences Penny Lovat

Still reeling from winning Best Partnership with Academia at the Medilink North Healthcare Awards. Our collaboration with Newcastle University was selected for its significant impact for melanoma patients. Big thanks to all the @AMLoBiosciences staff, our collaborators, and investors.

Alcohol on trains- I’d be for a complete ban. Currently on a 9.30am London North Eastern Railway train from Kings Cross, surrounded by a group of rowdy lads drinking consistently throughout. Had to ask one loitering in the aisle with his ass leaning on my shoulder to move. Not acceptable!

Great to see our own Professor Phil Sloan will be at #SMR2024 presenting the latest results for this important research project #melanoma Northern Accelerator Medilink North Newcastle Helix

The culmination of years of hard work but #AMBLor is now available for healthcare professionals in GB. Northern Accelerator Newcastle Hospitals Bionow Medilink North Northstar Ventures

AMBLor – a groundbreaking histopathological biomarker test from @AMLoBiosciences has been awarded the UKCA mark. medtechtomarket.com/latest-news/gr… #diagnostics #IVD #mediacaldevice

Another example of how #AMBLor is being used in the US to help Medical Professionals reassurance melanoma patients following their diagnosis. @AMLoBiosciences Northern Accelerator Northstar Ventures Newcastle Helix

Ready to promote @AMLoBiosciences at this morning’s Science, Innovation and Technology Committee meeting. Newcastle Helix Newcastle Hospitals Northern Accelerator Northstar Ventures The Biosphere British In Vitro Diagnostics Association (BIVDA) Bionow Medilink North

The UK has fantastic researchers and innovators up and down our country who make life better for all of us. But too often we don't hear enough about them. As the first of our new Science, Innovation and Technology Committee showcases, I invited Newcastle's @AMLoBiosciences to UK Parliament to share their story

At the start of our session yesterday, the CEO of @AMLoBiosciences told us about some of the limiting factors for innovators in the UK 👇

The future is bright for @AMLoBiosciences